Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Assets (2020 - 2025)

iSpecimen has reported Assets over the past 6 years, most recently at $9.5 million for Q4 2025.

  • Quarterly results put Assets at $9.5 million for Q4 2025, up 1.94% from a year ago — trailing twelve months through Dec 2025 was $9.5 million (up 1.94% YoY), and the annual figure for FY2025 was $9.5 million, up 1.94%.
  • Assets for Q4 2025 was $9.5 million at iSpecimen, up from $9.0 million in the prior quarter.
  • Over the last five years, Assets for ISPC hit a ceiling of $35.7 million in Q4 2021 and a floor of $6.0 million in Q2 2025.
  • Median Assets over the past 5 years was $16.3 million (2023), compared with a mean of $17.7 million.
  • Biggest five-year swings in Assets: surged 475.22% in 2021 and later plummeted 49.3% in 2025.
  • iSpecimen's Assets stood at $35.7 million in 2021, then tumbled by 31.08% to $24.6 million in 2022, then plummeted by 35.74% to $15.8 million in 2023, then plummeted by 40.89% to $9.4 million in 2024, then grew by 1.94% to $9.5 million in 2025.
  • The last three reported values for Assets were $9.5 million (Q4 2025), $9.0 million (Q3 2025), and $6.0 million (Q2 2025) per Business Quant data.